ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 103 filers reported holding ADICET BIO INC in Q3 2022. The put-call ratio across all filers is 0.71 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $281,771 | -78.2% | 31,518 | -65.3% | 0.00% | -87.5% |
| Q3 2022 | $1,292,000 | -80.0% | 90,849 | -79.4% | 0.01% | -92.0% |
| Q2 2022 | $6,446,000 | -26.9% | 441,518 | 0.0% | 0.10% | -7.4% |
| Q1 2022 | $8,817,000 | -2.1% | 441,518 | -14.3% | 0.11% | +18.7% |
| Q4 2021 | $9,007,000 | +317.8% | 515,000 | +87.3% | 0.09% | +911.1% |
| Q3 2021 | $2,156,000 | -23.8% | 275,000 | 0.0% | 0.01% | -43.8% |
| Q2 2021 | $2,830,000 | -36.6% | 275,000 | -19.4% | 0.02% | -33.3% |
| Q1 2021 | $4,464,000 | – | 341,269 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,115,385 | $30,017,000 | 10.26% |
| Foresite Capital Management V, LLC | 680,000 | $9,670,000 | 7.44% |
| Foresite Capital Opportunity Management V, LLC | 170,000 | $2,417,000 | 7.26% |
| DAFNA Capital Management LLC | 935,766 | $13,307,000 | 3.58% |
| COWEN AND COMPANY, LLC | 2,443,246 | $34,743,000 | 3.32% |
| JOHNSON & JOHNSON | 728,944 | $10,366,000 | 3.05% |
| Decheng Capital Management III (Cayman), LLC | 580,000 | $8,248,000 | 2.99% |
| Ally Bridge Group (NY) LLC | 244,400 | $3,475,000 | 2.29% |
| Orbimed Advisors | 7,447,140 | $105,898,000 | 1.97% |
| Cormorant Asset Management, LP | 1,400,000 | $19,908,000 | 1.39% |